Shizuoka, Japan

Tatsnobu Yoshioka

This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsnobu Yoshioka. Retrieved from https://idiyas.com/inventor/tatsnobu-yoshioka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tatsnobu Yoshioka

Introduction

Tatsnobu Yoshioka is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent.

Latest Patents

Yoshioka holds a patent for "Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems." This invention relates to conjugates that combine a lipid, a substrate peptide from mammalian cells, and a water-soluble polymer. These conjugates serve as colloidal carriers for tissue-specific drug delivery systems. The patent also covers methods for producing these conjugates and the use of peptide-water-soluble polymer conjugates with protective groups as intermediates.

Career Highlights

Yoshioka is currently associated with Astellas Pharma GmbH, where he continues to work on advancements in pharmaceutical technologies. His expertise in creating effective drug delivery systems has positioned him as a valuable asset in the industry.

Collaborations

Some of his notable coworkers include Maeda Atsushi and Akira Takagi, who collaborate with him on various projects within the pharmaceutical sector.

Conclusion

Tatsnobu Yoshioka's innovative work in drug delivery systems exemplifies the impact of scientific research on healthcare. His contributions continue to pave the way for advancements in targeted therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…